In the subcutaneous admixture experiments of GBM, colon and lung cancer models, the therapeutic efficacy of MSC-ENb-TRAIL was prominent as seen by the reduction in BLI intensities that are representative of tumor volumes. The gene discussed is TNFSF10; the disease is glioblastoma.